Hyaluronon injection shows no benefit over placebo for treatment of knee osteoarthritis .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy
Ann Rheum Dis. 1994 Aug;53(8):529-3491 patients with knee osteoarthritis were randomized to receive either 5 weekly intra-articular injections of hyaluronan, or to receive 5 placebo intra-articular injections. The purpose of the study was to determine the clinical effects of hyaluronan injection therapy, in terms of its efficacy and safety. Outcomes included VAS pain scores, knee tenderness, and range of motion assessed up to 5 weeks after the start of treatment. Additionally, adverse events and global assessments for patient and investigator were recorded. Results indicated no significant benefit of hyaluronan treatment over placebo for any outcome measure. A greater proportion of hyaluronan patients experienced pain and/or swelling at the injection site compared to patients in the placebo group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics